Theragen Etex Co.Ltd (066700) — Capital Reinvestment Ratio
Latest as of March 2026:
0.29x
Theragen Etex Co.Ltd (066700) has a Capital Reinvestment Ratio of 0.29x as of March 2026, meaning it reinvests 0% of its operating cash flow (₩3.08 Billion) in capital expenditures (₩897.88 Million). See Theragen Etex Co.Ltd (066700) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.29x
Capex / Operating Cash Flow
Operating Cash Flow
₩3.08 Billion
KRW
Capital Expenditures
₩897.88 Million
KRW
Data as of
Mar 2026
Most recent filing
Theragen Etex Co.Ltd Capital Reinvestment Ratio (2008–2025)
This chart tracks Theragen Etex Co.Ltd's Capital Reinvestment Ratio across 10 annual periods.
Annual Capital Reinvestment Ratio for Theragen Etex Co.Ltd (2008–2025)
Year-by-year Capital Reinvestment Ratio for Theragen Etex Co.Ltd from 2008 to 2025. For live market cap and broader valuation context, see Theragen Etex Co.Ltd stock valuation.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.47x | ₩10.97 Billion | ₩5.20 Billion | ▼ -92.6% |
| 2024 | 6.37x | ₩1.79 Billion | ₩11.39 Billion | ▲ +1510.4% |
| 2023 | 0.40x | ₩12.12 Billion | ₩4.80 Billion | ▼ -9.5% |
| 2022 | 0.44x | ₩9.59 Billion | ₩4.19 Billion | ▼ -36.3% |
| 2021 | 0.69x | ₩4.01 Billion | ₩2.75 Billion | ▲ +201.3% |
| 2020 | 0.23x | ₩13.23 Billion | ₩3.01 Billion | ▼ -99.8% |
| 2019 | 123.01x | ₩37.69 Million | ₩4.64 Billion | ▲ +7384.3% |
| 2017 | 1.64x | ₩1.78 Billion | ₩2.92 Billion | ▼ -96.4% |
| 2014 | 45.34x | ₩39.95 Million | ₩1.81 Billion | ▲ +37789.2% |
| 2008 | 0.12x | ₩3.14 Billion | ₩376.03 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow